You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Exercise Disclosure
Sloan Sheldon · SEC Form 4 · Filed Jun 3, 2026
Exercise
Calculated transaction value
$228.82K
Sloan Sheldon Chief Medical Officer
SYRE
Spyre Therapeutics
SYRE
Transaction date
Jun 3, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed same day
SYRE daily price context
Close on/before transaction
$73.52
Jun 3, 2026
First close after public filing
$78.48
Jun 4, 2026
30-day return after filing
+13.07%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,333 shares @ $27.46
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001636282-26-000078
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$853.8K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE Current | Exercise | Jun 3, 2026 | $228.82K |
| Spyre Therapeutics, Inc. SYRE | Sale | Jun 3, 2026 | $624.98K |
| Spyre Therapeutics, Inc. SYRE | Exercise | Jun 3, 2026 | $0 |